Consulting Firm McKinsey Concludes Opioid Litigation Settlement With $78M Agreement
Portfolio Pulse from Vandana Singh
McKinsey & Co has agreed to a $78 million settlement to resolve allegations related to the opioid epidemic, particularly its involvement with Purdue Pharma. The settlement is pending judicial approval and addresses claims from third-party payers such as insurers. This follows a previous $230 million settlement with U.S. local governments and school districts over similar allegations.
January 02, 2024 | 12:56 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cigna, as a third-party payer, may be indirectly affected by the settlement due to its role as an insurer. However, the article does not specify Cigna's involvement.
Cigna is mentioned as a potential third-party payer but without specific details on its involvement or impact from the settlement.
CONFIDENCE 50
IMPORTANCE 20
RELEVANCE 10
NEUTRAL IMPACT
CVS Health may be indirectly affected by the settlement as it operates pharmacies that could be involved in opioid distribution. The article does not mention CVS Health directly.
CVS Health is a potential indirect stakeholder in the opioid litigation due to its pharmacy operations, but the article does not provide details on its involvement.
CONFIDENCE 50
IMPORTANCE 20
RELEVANCE 10
NEUTRAL IMPACT
Quest Diagnostics, as a provider of diagnostic information services, may be tangentially related to the opioid crisis but is not directly mentioned or implicated in the settlement.
Quest Diagnostics is not directly mentioned in the context of the opioid settlement, and its connection to the litigation is unclear.
CONFIDENCE 50
IMPORTANCE 10
RELEVANCE 5
NEUTRAL IMPACT
Humana, as an insurer, could be indirectly affected by the settlement due to its role in providing health benefits. The article does not detail Humana's specific involvement.
Humana is mentioned as a potential third-party payer but without specific details on its involvement or impact from the settlement.
CONFIDENCE 50
IMPORTANCE 20
RELEVANCE 10
NEUTRAL IMPACT
UnitedHealth Group, through its insurance and health services, may be indirectly impacted by the settlement. The article does not specify UnitedHealth's direct involvement.
UnitedHealth Group is a potential third-party payer but the article lacks details on its specific involvement in the settlement.
CONFIDENCE 50
IMPORTANCE 20
RELEVANCE 10
NEUTRAL IMPACT
Walgreens Boots Alliance, as a pharmacy operator, may be indirectly related to the opioid litigation but is not directly mentioned in the settlement.
Walgreens Boots Alliance is a potential indirect stakeholder in the opioid litigation due to its pharmacy operations, but the article does not provide details on its involvement.
CONFIDENCE 50
IMPORTANCE 20
RELEVANCE 10